Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy

American Journal of Medical Genetics. Part a
Lainie Friedman Ross

Abstract

In this manuscript, I examine four overlapping policy and ethical issues regarding screening newborns (and infants) for Duchenne muscular dystrophy (DMD). First, what are the risks and benefits of expanding newborn screening (NBS) to include DMD? Second, if NBS were to expand to include DMD, should it require informed consent? Third, should NBS for DMD be limited to boys? Why or why not? Fourth, when is the ideal timing for screening (prenatal, newborn, or later in infancy) and what factors influence this determination? I argue that decisions about when, how, and whom to test reflect a tension between maximizing uptake and diagnosis versus maximizing autonomy and choice with respect to genetic information. I conclude that screening for DMD is a valid moral option, but not as part of the mandatory NBS population program. Rather, I propose that screening for DMD should be offered only on a voluntary basis beyond the newborn period. I support offering this screening to families of young boys and girls to ensure that all children and their families can benefit from early diagnosis and its reproductive implications. A rigorous consent process will be necessary to ensure that the decision whether or not to test is a voluntary and inf...Continue Reading

References

Jun 10, 1978·Lancet·L M Drummond, A M Veale
Apr 1, 1976·Archives of Disease in Childhood·N Gilboa, J R Swanson
Jul 1, 1989·Biological Trace Element Research·D E Coppen-Jaeger, M Wilhelm
Apr 1, 1988·Developmental Medicine and Child Neurology·J R MillerN C Schock
Oct 15, 1983·British Medical Journal·T O'BrienP S Harper
Apr 27, 1984·Clinica Chimica Acta; International Journal of Clinical Chemistry·A P Orfanos, E W Naylor
Jul 13, 1984·Science·P T Rowley
Jan 22, 1982·JAMA : the Journal of the American Medical Association·D E CrispP F Bray
Feb 1, 1982·Journal of Medical Genetics·R SkinnerJ Syme
Mar 4, 1995·Lancet·P D Marshall, C S Galasko
Jan 1, 1994·International Journal of Technology Assessment in Health Care·M M Kaback
Jun 12, 1993·BMJ : British Medical Journal·H BekkerT Marteau
Aug 1, 1993·Journal of Medical Genetics·E HildesC R Greenberg
Mar 1, 1993·Journal of Medical Ethics·R F Chadwick
Feb 6, 1993·BMJ : British Medical Journal·D M BradleyA J Clarke
May 1, 1996·JAMA : the Journal of the American Medical Association·L PolitanoL I Comi
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A F PatenaudeF P Li
Jun 28, 1996·American Journal of Medical Genetics·E P HoffmanP Blattner
Aug 1, 1997·American Journal of Public Health·N A Holtzman
Aug 5, 1999·Autoimmunity·G FlandersM Rewers
Jan 8, 2000·Acta Paediatrica. Supplement·R J Pollitt
May 29, 2000·The Journal of the American Board of Family Practice·R M Ewart
May 22, 2001·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·A E Raffle
Jun 5, 2001·Pediatrics·UNKNOWN Committee on Bioethics
Aug 14, 2001·Clinics in Perinatology·C F Whitten, W Whitten-Shurney
Oct 11, 2001·Molecular Genetics and Metabolism·B L Therrell
Mar 8, 2002·Archives of Disease in Childhood. Fetal and Neonatal Edition·E P ParsonsD M Bradley
May 25, 2002·Journal of Child Neurology·Brenda L Y Wong, Caroline Christopher
Jul 13, 2002·BMJ : British Medical Journal·Theresa M Marteau, Ann Louise Kinmonth

❮ Previous
Next ❯

Citations

Dec 23, 2011·Journal of Inherited Metabolic Disease·Lainie Friedman Ross
Nov 11, 2011·European Journal of Human Genetics : EJHG·Yvonne BombardPranesh Chakraborty
Jan 24, 2013·European Journal of Human Genetics : EJHG·Stuart J MoatLouise Hartley
Jun 21, 2012·European Journal of Human Genetics : EJHG·Kristien HensUNKNOWN PPPC of the European Society of Human Genetics
May 17, 2013·European Journal of Human Genetics : EJHG·Wybo J Dondorp, Guido M W R de Wert
Nov 21, 2007·Current Opinion in Pediatrics·Alex R Kemper, Melissa A Wake
Apr 17, 2010·Public Health Genomics·Wylie BurkeN Press
Sep 1, 2007·Journal of Empirical Research on Human Research Ethics : JERHRE·Lisa FeuchtbaumStan Sciortino
May 24, 2014·International Journal of Environmental Research and Public Health·Katharina Elisabeth Fischer, Wolf Henning Rogowski
Mar 18, 2009·American Journal of Medical Genetics. Part a·Kruti Acharya, Lainie Friedman Ross
Mar 28, 2012·Annals of Neurology·Jerry R MendellRobert B Weiss
Mar 16, 2013·American Journal of Medical Genetics. Part a·Sandra Daack-HirschChristopher Cunniff
Jan 14, 2011·Acta Paediatrica·Amy S HerlihyRobert I McLachlan
Jan 1, 2011·Developmental Disabilities Research Reviews·Darrel J Waggoner, Christopher A Tan
Nov 27, 2014·Annals of Neurology·Michele A ScullyJennifer M Kwon
Nov 8, 2012·International Journal of Audiology·Luan Linden PhillipsClaire Packer
May 30, 2015·Pediatric Clinics of North America·Lainie Friedman Ross
Mar 30, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Lauren E CiprianoGregory S Zaric
May 14, 2016·Muscle & Nerve·Jennifer M KwonAnne M Connolly
Jul 1, 2015·BMC Medical Informatics and Decision Making·Sarah E LillieBrian J Zikmund-Fisher
Jan 14, 2018·European Journal of Human Genetics : EJHG·David J CooteKristen J Nowak
Feb 23, 2018·European Journal of Human Genetics : EJHG·David CooteKristen J Nowak
Jan 30, 2015·European Journal of Human Genetics : EJHG·Siaw H WongSylvia A Metcalfe
Jul 31, 2014·European Journal of Human Genetics : EJHG·Sally LawtonSylvia A Metcalfe
Sep 6, 2012·Journal of Developmental and Behavioral Pediatrics : JDBP·Gail GellerCynda H Rushton
Apr 15, 2015·Current Opinion in Endocrinology, Diabetes, and Obesity·Amy S Herlihy, Robert I McLachlan
Jul 22, 2020·Developmental Medicine and Child Neurology·Paula van DommelenPaul H Verkerk
Jun 28, 2018·Journal of Community Genetics·Angus J Clarke, Carina Wallgren-Pettersson
Aug 3, 2019·NeoReviews·Lainie Friedman Ross, Jennifer M Kwon
Feb 15, 2020·International Journal of Molecular Sciences·Dylan MordauntMaria Fuller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.